Q Bio Revenue and Competitors

Location

$84M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Q Bio's estimated annual revenue is currently $6M per year.(i)
  • Q Bio's estimated revenue per employee is $128,617
  • Q Bio's total funding is $84M.

Employee Data

  • Q Bio has 47 Employees.(i)
  • Q Bio grew their employee count by 7% last year.

Q Bio's People

NameTitleEmail/Phone
1
VP RadiomicsReveal Email/Phone
2
Head Platform EngineeringReveal Email/Phone
3
Head Product Management, GeminiReveal Email/Phone
4
Hardware Engineering ManagerReveal Email/Phone
5
Technical Product ManagerReveal Email/Phone
6
Software EngineerReveal Email/Phone
7
Software EngineerReveal Email/Phone
8
Founder/CEO/CTOReveal Email/Phone
9
Senior Computational Software EngineerReveal Email/Phone
10
General Manager, Center OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Q Bio?

The Physical of the Future: Q Bio gives you a deeper understanding of your body and how it's changing, so you have more control over your health. Our Q Exam is based on landmark systems biology research done at Stanford University. In about 75 minutes, we take blood, saliva, urine and a non-invasive whole-body scan from which we measure over 3000 clinically-relevant genetic, chemical, and anatomical biomarkers to build the world's most comprehensive quantitative snapshot of your health at a point in time. We believe people should know more, worry less... and that prevention is better than the best cure.

keywords:Biotechnology, Healthcare

$84M

Total Funding

47

Number of Employees

$6M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Q Bio News

2022-04-20 - INmune Bio, Inc. to Report First Quarter 2022 Financial ...

Please ask for the INmune Bio Third Quarter Conference Call when reaching ... the Company's Quarterly Reports on Form 10-Q and the Company's...

2022-04-20 - Bio-Rad Reports First-Quarter 2022 Financial Results

BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), ... 2021 and its Quarterly Report on Form 10-Q for the quarter ended March...

2022-04-19 - Layoffs hit another biotech as Duchenne player Solid Bio cuts ...

Solid Bio is reducing its workforce by 35%, according to an SEC filing for ... organizational efficiencies,” Solid Bio said in its 10-Q. “We...

2021-04-30 - Q Bio Launches Clinical “Digital Twin” Platform, Whole Body Scanner

What You Should Know: – Q Bio, a Redwood City, CA-based company building technology for the Physical of the Future, unveiled its “digital twin” platform, the first to capture and monitor comprehensive baseline patient health in a scalable virtual model. – In addition, the company announced an ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.9M47-6%N/A
#2
$13.3M477%N/A
#3
$3.8M4812%N/A
#4
$5.5M49-29%N/A
#5
$1.7M49N/AN/A